Physiology and pathology of endothelin-1 in renal mesangium. (Q35211305)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12954590%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

review article

1 reference

title

Physiology and pathology of endothelin-1 in renal mesangium (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12954590%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12954590%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

author name string

Donald E Kohan

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12954590%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

publication date

1 October 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12954590%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Physiology - Renal Physiology

7 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12954590%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

285

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12954590%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12954590%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

F579-89

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12954590%20AND%20SRC:MED&resulttype=core&format=json

Vezf1/DB1 is an endothelial cell-specific transcription factor that regulates expression of the endothelin-1 promoter

7 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00019.2003

Mesangial cell, glomerular and renal vascular responses to endothelin in the rat kidney. Elucidation of signal transduction pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00019.2003

Clinical efficacy of sitaxsentan, an endothelin-A receptor antagonist, in patients with pulmonary arterial hypertension: open-label pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00019.2003

Regression of renal vascular fibrosis by endothelin receptor antagonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00019.2003

Rho-kinase inhibition blunts renal vasoconstriction induced by distinct signaling pathways in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00019.2003

High glucose-induced mesangial cell altered contractility: role of the polyol pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00019.2003

RGS3 inhibits G protein-mediated signaling via translocation to the membrane and binding to Galpha11

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00019.2003

Effect of a specific endothelin receptor A antagonist and an angiotensin-converting enzyme inhibitor on glomerular mRNA levels for extracellular matrix components, metalloproteinases (MMP) and a tissue inhibitor of MMP in aminonucleoside nephrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00019.2003

Thrombin suppresses endothelial nitric oxide synthase and upregulates endothelin-converting enzyme-1 expression by distinct pathways: role of Rho/ROCK and mitogen-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00019.2003

Attenuation of puromycin aminonucleoside-induced glomerular lesions in rats by CGS 26303, a dual neutral endopeptidase/endothelin-converting enzyme inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00019.2003

Biphasic activation of p21ras by endothelin-1 sequentially activates the ERK cascade and phosphatidylinositol 3-kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00019.2003

Endothelin-1 induces serine phosphorylation of the adaptor protein p66Shc and its association with 14-3-3 protein in glomerular mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00019.2003

Signaling pathways and late-onset gene induction associated with renal mesangial cell hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00019.2003

Effects of endothelin receptor antagonists on the progression of diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00019.2003

High glucose-enhanced mesangial cell extracellular signal-regulated protein kinase activation and alpha1(IV) collagen expression in response to endothelin-1: role of specific protein kinase C isozymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00019.2003

Endothelin-1 activates mesangial cell ERK1/2 via EGF-receptor transactivation and caveolin-1 interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00019.2003

Effect of reactive oxygen species on endothelin-1 production by human mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00019.2003

Successful treatment of systemic sclerosis digital ulcers and pulmonary arterial hypertension with endothelin receptor antagonist bosentan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00019.2003

Endothelin production in cultured mesangial cells of spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00019.2003

beta -Arrestin-mediated recruitment of the Src family kinase Yes mediates endothelin-1-stimulated glucose transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00019.2003

Cyclooxygenase-2 inhibits tumor necrosis factor alpha-mediated apoptosis in renal glomerular mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00019.2003

Nonpeptidic endothelin-converting enzyme inhibitors and their potential therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00019.2003

Do results of the ENABLE (Endothelin Antagonist Bosentan for Lowering Cardiac Events in Heart Failure) study spell the end for non-selective endothelin antagonism in heart failure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00019.2003

RITZ-5: randomized intravenous TeZosentan (an endothelin-A/B antagonist) for the treatment of pulmonary edema: a prospective, multicenter, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00019.2003

Endothelin system: the double-edged sword in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00019.2003

Endothelins in the normal and diseased kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00019.2003

Angiotensin II stimulates endothelin-1 secretion in cultured rat mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00019.2003

C-type natriuretic peptide inhibits thrombin- and angiotensin II-stimulated endothelin release via cyclic guanosine 3',5'-monophosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00019.2003

Heparin inhibits endothelin-1 production in cultured rat mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00019.2003

The effect of an endothelin-receptor antagonist, bosentan, on blood pressure in patients with essential hypertension. Bosentan Hypertension Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00019.2003

Protein tyrosine kinase PYK2 involved in Ca(2+)-induced regulation of ion channel and MAP kinase functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00019.2003

Clinical Trials Update: CAPRICORN, COPERNICUS, MIRACLE, STAF, RITZ-2, RECOVER and RENAISSANCE and cachexia and cholesterol in heart failure. Highlights of the Scientific Sessions of the American College of Cardiology, 2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00019.2003

Hemodynamic and neurohumoral effects of selective endothelin A (ET(A)) receptor blockade in chronic heart failure: the Heart Failure ET(A) Receptor Blockade Trial (HEAT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00019.2003

The p66shc adaptor protein controls oxidative stress response and life span in mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00019.2003

Calcineurin-GATA4 pathway is involved in beta-adrenergic agonist-responsive endothelin-1 transcription in cardiac myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00019.2003

Biphenylsulfonamide endothelin receptor antagonists. 4. Discovery of N-[[2'-[[(4,5-dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]- 2-yl]methyl]-N,3,3-trimethylbutanamide (BMS-207940), a highly potent and orally active ET(A) sele

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00019.2003

Darusentan: an effective endothelinA receptor antagonist for treatment of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00019.2003

Upregulation of osteopontin in ischemia-induced renal failure in rats: a role for ET-1?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00019.2003

Role of endothelin in acute renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00019.2003

Endothelin (ET)-3 stimulates cyclic guanosine 3',5'-monophosphate production via ETB receptor by producing nitric oxide in isolated rat glomerulus, and in cultured rat mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00019.2003

Mixed lineage kinase 3 inhibits platelet-derived growth factor-stimulated DNA synthesis and matrix mRNA expression in mesangial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00019.2003

Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00019.2003

A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00019.2003

New therapeutics that antagonize endothelin: promises and frustrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00019.2003

Regulation of endothelin-1 production in cultured rat mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00019.2003

Efficacy and safety of the endothelin, receptor antagonist TAK-044 in treating subarachnoid hemorrhage: a report by the Steering Committee on behalf of the UK/Netherlands/Eire TAK-044 Subarachnoid Haemorrhage Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00019.2003

Renal damage and salt-dependent hypertension in aged transgenic mice overexpressing endothelin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00019.2003

Endothelin-1 stimulates contraction of rat glomerular mesangial cells and potentiates beta-adrenergic-mediated cyclic adenosine monophosphate accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00019.2003

Cytosolic and nuclear signaling by endothelin peptides: mesangial response to glomerular injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00019.2003

Endothelins: multifunctional renal peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00019.2003

Endothelin stimulates phospholipase C, Na+/H+ exchange, c-fos expression, and mitogenesis in rat mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00019.2003

Protein-tyrosine kinase Pyk2 mediates endothelin-induced p38 MAPK activation in glomerular mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00019.2003

Renal protective effect of YM598, a selective endothelin ET(A) receptor antagonist, against diabetic nephropathy in OLETF rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00019.2003

Cyclin D1, p16, and retinoblastoma gene regulate mitogenic signaling of endothelin in rat mesangial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00019.2003

MAPK signaling and the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00019.2003

Mutations throughout the S6 region of the hKv1.5 channel alter the stability of the activation gate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00019.2003

Ca2+/calmodulin-dependent protein kinase II stimulates c-fos transcription and DNA synthesis by a Src-based mechanism in glomerular mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00019.2003

Endothelin rapidly stimulates mitogen-activated protein kinase activity in rat mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00019.2003

Mesangial cell protein kinase C isozyme activation in the diabetic milieu

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00019.2003

Molecular regulation of the endothelin-1 gene by hypoxia. Contributions of hypoxia-inducible factor-1, activator protein-1, GATA-2, AND p300/CBP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00019.2003

A novel potent vasoconstrictor peptide produced by vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00019.2003

Endothelin is a potent inhibitor of matrix metalloproteinase-2 secretion and activation in rat mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00019.2003

Role of thromboxane A2, endothelin-1 and endothelin-3 in rat nephrotoxic serum nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00019.2003

10.1152/AJPRENAL.00019.2003

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12954590%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference